Introduction Pocket Metab Impressum
··· Diseases ··· Symptoms ··· Lab Parameters ··· Authors ··· Ramedis ··· BH4 Patient List of associated diseases and any hint to further information based on the descripton or synonyms to the accession number HMDB00051
Ammonia
Ammonia is a colorless alkaline gas with a characteristic smell. Ammonia is a basic gas and one of the most abundant nitrogen-containing compounds in the atmosphere. Ammonia is an irritant gas with a characteristic pungent odor, which is widely used in industry. Inasmuch as ammonia is highly soluble in water and, upon inhalation, is deposited in the upper airways, occupational exposures to ammonia have commonly been associated with sinusitis, upper airway irritation, and eye irritation. Acute exposures to high levels of ammonia have also been associated with diseases of the lower airways and interstitial lung. Ammonia is a neurotoxin that predominantly affects astrocytes. Disturbed mitochondrial function and oxidative stress, factors implicated in the induction of the mitochondrial permeability transition, appear to be involved in the mechanism of ammonia neurotoxicity. Ammonia is formed in nearly all tissues and organs of the vertebrate organism; it is the most common endogenous neurotoxic compounds; it affects the glutamatergic and GABAergic neuronal systems, the two prevailing neuronal systems of the cortical structures. Ammonia is well recognized to be central in the pathogenesis of hepatic encephalopathy and has been of importance to generations dating back to the early Egyptians. The gut produces ammonia which is metabolized in the liver and almost all organ systems are involved in ammonia metabolism. Colonic bacteria produce ammonia by splitting urea and possibly amino acids; this does not explain hyperammonemia and hepatic encephalopathy. The alternative explanation is that hyperammonemia is the result of intestinal breakdown of amino acids, especially glutamine. The intestines have a high glutaminase activity, predominantly located in the enterocytes, and only a little glutamine synthetase activity, making it a major glutamine-consuming organ. The kidney is an important source of blood ammonia in patients with liver disease. Ammonia is also taken up by the muscle and brain in hepatic coma, and there is confirmation that ammonia is metabolized in muscle. The excessive formation of ammonia in the brains of Alzheimer's disease patients has been demonstrated, and it has been shown that some Alzheimer's disease patients exhibit elevated blood ammonia concentrations. Ammonia is the most important natural modulator of lysosomal protein processing: there is evidence for the involvement of aberrant lysosomal processing of beta-amyloid precursor protein (beta-APP) in the formation of amyloid deposits. Inflammatory processes and activation of microglia are widely believed to be implicated in the pathology of Alzheimer's disease. Ammonia is able to affect the characteristic functions of microglia, such as endocytosis, and cytokine production. Based on these facts, an ammonia hypothesis of Alzheimer's disease has been suggested. (PMID: 17006913, 16167195, 15377862, 15369278, 12020619)
Please note: All linked information should be double checked for accuracy!
  1. ARGININOSUCCINIC ACIDURIA (ASL)
  2. MYOADENYLATE DEAMINASE DEFICIENCY
  3. MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY (MCAD)
  4. ARGININEMIA. HYPERARGININEMIA, ARGINASE DEFICIENCY
  5. LYSINURIC PROTEIN INTOLERANCE (LPI)
  6. CARBAMOYL PHOSPHATE SYNTHETASE DEFICIENCY (CPS)
  7. CITRULLINEMIA TYPE I
  8. CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY
  9. PYRUVATE CARBOXYLASE DEFICIENCY
  10. PYRUVATE DEHYDROGENASE DEFICIENCY (E1)
  11. PHENYLKETONURIA (PKU)
  12. GLYCOGENOSIS, TYPE V. McARDLE DISEASE
  13. HYPERORNITHINEMIA WITH GYRATE ATROPHY (HOGA)
  14. HISTIDINEMIA
  15. PRIMARY HYPEROXALURIA II, PH2
  16. PRIMARY HYPEROXALURIA I, PH1
  17. ORNITHINE TRANSCARBAMYLASE DEFICIENCY (OTC)
  18. N-ACETYLGLUTAMATE SYNTHETASE DEFICIENCY. NAGS DEFICIENCY
  19. HYPERGLYCINEMIA, NON-KETOTIC
  20. HYPERLYSINEMIA I, FAMILIAL
  21. HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA [HHH-SYNDROME]
  22. MUCOPOLYSACCHARIDOSIS III. SAN FILIPPO A SYNDROME
  23. MUCOLIPIDOSIS II
  24. OCULOCEREBRORENAL SYNDROME OF LOWE
  25. AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY
  26. HYPERPHENYLALANINEMIA DUE TO PTERIN-4a-CARBINOLAMINE DEHYDRATASE
  27. PRIMARY HYPOMAGNESEMIA
  28. HYPERLYSINEMIA II OR SACCHAROPINURIA
  29. MONOAMINE OXIDASE-A DEFICIENCY (MAO-A)
  30. HYPERINSULINISM-HYPERAMMONEMIA SYNDROME
  31. PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY